Skip to search.
 TSX Up0.88% TSX Ventures 0.00%

More On DIVISLAB.BO

Quotes

Charts

News & Info

  • Headlines
  • Company Events

Company

Analyst Coverage

  • Analyst Opinion
  • Analyst Estimates

Ownership

  • Major Holders
  • Insider Transactions
  • Insider Roster

Financials


Divi's Laboratories Limited (DIVISLAB.BO)

-BSE

1,007.50 Down 79.20(7.29%) 6:14AM EDT

Add to Portfolio
ProfileGet Profile for:
Divi's Laboratories Limited
Divi Towers, 7-1-77/E/1/303
Dharam Karan Road
Hyderabad, 500016
India - Map
Phone: 91 40 2378 6300
Fax: 91 40 2378 6460
Website: http://www.divislabs.com

Details 
Index Membership:N/A
Sector:Healthcare
Industry:Drugs - Generic
Full Time Employees:N/A

Business Summary 

Divi’s Laboratories Limited engages in the manufacture of active pharmaceutical ingredients (APIs) and intermediates for generics in India. It provides building blocks for peptides and nucleotides; carotenoids, such as apocarotenal, betacarotene, lycopene, astaxanthin, and canthaxanthin; chiral ligands, including binol and binap; amino acids, such as BOC, FMOC, and CBZ protected amino acids; and neutraceuticals. The company also offers custom synthesis and contract research services of APIs and advanced intermediates for discovery compounds to pharma companies. It also exports its products to European and American countries. The company was formerly known as Divi’s Research Center and changed its name to Divi’s Laboratories Limited in 1994. Divi’s Laboratories Limited was founded in 1990 and is headquartered in Hyderabad, India.

Key Statistics


Company Websites 
Home Page
Search Yahoo! for:
More on Divi's Laboratories Limited

Key Executives 
 PayExercised
Dr. Murali Krishna Prasad Divi M. Pharm, Ph.D., 62
Chairman and Managing Director
231.48MN/A
Sri L. Kishore Babu B.Com, FICWA, 61
Chief Financial Officer and Member of Shareholders/Investors Grievance Committee
N/AN/A
Mr. Kiran S. Divi B. Pharm., 37
Pres of Operations, Director of Operations, Exec. Director and Member of Allotment Committee
80.75MN/A
Mr. Venkata Ramana Nandimpalli B.Sc.(Chem), 56
Exec. Director and Member of Shareholders/Investors Grievance Committee
118.90MN/A
Mr. M. Ramesh Babu B.Sc., 47
Chief Technologist
N/AN/A
Amounts are as of 2012-12-30 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year.
Currency in INR.